ARISAPH PHARMACEUTICALS

Arisaph Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing therapies for cancer, cardiovascular disease, and diabetes. Its products include dipeptidylpeptidase IV inhibitors, stable GLP-1 agonists, HDL modulators and plaque reducers, and tumor activated pro-soft drugs. The company was founded in 1999 and is based in Boston, Massachusetts.

#People #Website #More

ARISAPH PHARMACEUTICALS

Industry:

Biotechnology Diabetes Therapeutics

Founded:

1999-01-01

Address:

Boston, Massachusetts, United States

Country:

United States

Website Url:

http://www.arisaph.com

Total Employee:

11+

Status:

Active

Contact:

Email Addresses:

[email protected]

Total Funding:

10 M USD

Technology used in webpage:

Apache Euro New Relic Network Solutions DNS Symantec Secure Site Citrix NetScaler Confluence Networks

Current Advisors List

not_available_image

Thomas Koestler Member Board of Directors @ Arisaph Pharmaceuticals
Board_member
2010-02-01

Current Employees Featured

william-bachovchin_image

William Bachovchin
William Bachovchin CSO & Co-Founder @ Arisaph Pharmaceuticals
CSO & Co-Founder

christopher-p-kiritsy_image

Christopher P. Kiritsy
Christopher P. Kiritsy Founder and President and CEO @ Arisaph Pharmaceuticals
Founder and President and CEO
1999-01-01

Founder

christopher-p-kiritsy_image

Christopher P. Kiritsy

william-bachovchin_image

William Bachovchin

Official Site Inspections

http://www.arisaph.com

Host Informations
Whois Informations

Loading ...

More informations about "Arisaph Pharmaceuticals" on Search Engine